{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:50:00Z","timestamp":1782420600398,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R44AI150237-01"],"award-info":[{"award-number":["1R44AI150237-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003187","name":"NSF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1644868"],"award-info":[{"award-number":["1644868"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CHE-1726291"],"award-info":[{"award-number":["CHE-1726291"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejmech.2022.115043","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T19:34:15Z","timestamp":1672428855000},"page":"115043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Discovery of potent Plasmodium falciparum protein kinase 6 (PfPK6) inhibitors with a type II inhibitor pharmacophore"],"prefix":"10.1016","volume":"249","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3232-2373","authenticated-orcid":false,"given":"Han Wee","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Kwarcinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandi","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisha","family":"Avalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy M.","family":"Havener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chirgwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem A.","family":"Galal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Derbyshire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Zutshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5973-5798","authenticated-orcid":false,"given":"David H.","family":"Drewry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.115043_bib1","series-title":"World Malaria Report 2021","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.ejmech.2022.115043_bib2","volume":"3","author":"Phillips","year":"2017","journal-title":"Malaria. Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejmech.2022.115043_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.115043_bib4","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum Kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2022.115043_bib5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","article-title":"Association of Plasmodium falciparum Kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study","volume":"21","author":"Uwimana","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.115043_bib6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.115043_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial Medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2022.115043_bib8","series-title":"Protein Phosphorylation in Parasites","first-page":"261","article-title":"Kinase inhibitors among hits from malaria cellular screens","author":"Brown","year":"2013"},{"key":"10.1016\/j.ejmech.2022.115043_bib9","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.4155\/fmc.12.183","article-title":"Plasmodium kinases as targets for new-generation antimalarials","volume":"4","author":"Lucet","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1021\/acsinfecdis.0c00724","article-title":"Plasmodium kinases as potential drug targets for malaria: challenges and opportunities","volume":"7","author":"Arendse","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.115043_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2164-5-79","article-title":"Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote","volume":"5","author":"Ward","year":"2004","journal-title":"BMC Genom."},{"key":"10.1016\/j.ejmech.2022.115043_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/prot.20278","article-title":"A genomic perspective of protein kinases in Plasmodium falciparum","volume":"58","author":"Anamika","year":"2005","journal-title":"Proteins: Struct., Funct., Bioinf."},{"key":"10.1016\/j.ejmech.2022.115043_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ncomms1558","article-title":"Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum","volume":"2","author":"Solyakov","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2022.115043_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/science.aap7847","article-title":"Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis","volume":"360","author":"Zhang","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.115043_bib15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","article-title":"Trends in kinase drug discovery: targets, indications and inhibitor design","volume":"20","author":"Attwood","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.115043_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2022.115043_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41467-017-00572-x","article-title":"A potent series targeting the malarial CGMP-dependent protein kinase clears infection and blocks transmission","volume":"8","author":"Baker","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2022.115043_bib18","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.chembiol.2020.04.001","article-title":"Inhibition of resistance-refractory P. falciparum kinase PKG delivers prophylactic, blood stage, and transmission-blocking antiplasmodial activity","volume":"27","author":"Vanaerschot","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.115043_bib19","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acs.jmedchem.9b01099","article-title":"Development of chemical entities endowed with potent fast-killing properties against Plasmodium falciparum malaria parasites","volume":"62","author":"Matralis","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau1682","article-title":"Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target","volume":"365","author":"Alam","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.115043_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/bj3470255","article-title":"PfPK6, a novel cyclin-dependent kinase\/mitogen-activated protein kinase-related protein kinase from Plasmodium falciparum","volume":"347","author":"Bracchi-Ricard","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2022.115043_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149996","article-title":"Biochemical screening of five protein kinases from Plasmodium falciparum against 14,000 cell-active compounds","volume":"11","author":"Crowther","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.115043_bib23","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1021\/ja104491h","article-title":"A coiled-coil enabled split-luciferase three-hybrid system: applied toward profiling inhibitors of protein kinases","volume":"132","author":"Jester","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.115043_bib24","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1021\/jm030427r","article-title":"Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, Structure\u2212Activity relationships, and antitumor activities of N-phenyl-N \u2018-{4-(4-Quinolyloxy)Phenyl}ureas","volume":"48","author":"Kubo","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib25","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1021\/acs.jmedchem.8b00672","article-title":"Discovery of N-[4-(Quinolin-4-Yloxy)Phenyl]Benzenesulfonamides as novel AXL kinase inhibitors","volume":"61","author":"Szabadkai","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib26","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1021\/jm201265f","article-title":"Testing the promiscuity of commercial kinase inhibitors against the AGC kinase group using a split-luciferase screen","volume":"55","author":"Jester","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1039\/C3MD00275F","article-title":"When tight is too tight: dasatinib and its lower affinity analogue for profiling kinase inhibitors in a three-hybrid split-luciferase system","volume":"5","author":"Ogunleye","year":"2014","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2022.115043_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.115043_bib29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nchembio799","article-title":"Rational design of inhibitors that bind to inactive kinase conformations","volume":"2","author":"Liu","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.115043_bib30","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1021\/cb500129t","article-title":"Exploration of type II binding mode: a privileged approach for kinase inhibitor focused drug discovery?","volume":"9","author":"Zhao","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.115043_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1021\/jm400378w","article-title":"A knowledge-based structural database to navigate kinase\u2013ligand interaction space","volume":"57","author":"van Linden","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/prot.10259","article-title":"Kinase inhibitors and the case for CH-O hydrogen bonds in protein-ligand binding","volume":"49","author":"Pierce","year":"2002","journal-title":"Proteins Struct. Funct. Genet."},{"key":"10.1016\/j.ejmech.2022.115043_bib33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00726-007-0015-4","article-title":"Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study","volume":"34","author":"Panigrahi","year":"2008","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejmech.2022.115043_bib34","unstructured":"Williams, R. pKa values in water compilation. https:\/\/organicchemistrydata.org\/hansreich\/resources\/pka\/pka_data\/pka-compilation-williams.pdf (accessed 2022-November-9)."},{"key":"10.1016\/j.ejmech.2022.115043_bib35","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1021\/jm000206a","article-title":"4-Anilino-6,7-Dialkoxyquinoline-3-Carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors","volume":"43","author":"Wissner","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib36","doi-asserted-by":"crossref","first-page":"14626","DOI":"10.1021\/acs.jmedchem.0c01174","article-title":"A chemical probe for dark kinase STK17B derives its potency and high selectivity through a unique P-loop conformation","volume":"63","author":"Picado","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib37","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1021\/jp811250r","article-title":"Estimation of molecular acidity via electrostatic potential at the nucleus and valence natural atomic orbitals","volume":"113","author":"Liu","year":"2009","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.ejmech.2022.115043_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jcc.25090","article-title":"Molecular acidity: an accurate description with information-theoretic approach in density functional reactivity theory","volume":"39","author":"Cao","year":"2018","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cplett.2012.01.014","article-title":"Towards understanding proton affinity and gas-phase basicity with density functional reactivity theory","volume":"527","author":"Huang","year":"2012","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.ejmech.2022.115043_bib40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/ijms22020566","article-title":"The kinase chemogenomic set (KCGS): an open science resource for kinase vulnerability identification","volume":"22","author":"Wells","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.115043_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/jm500480k","article-title":"Discovery of type II inhibitors of TGF\u03b2-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)","volume":"58","author":"Tan","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib42","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1021\/acschembio.8b00154","article-title":"Selective inhibition of the myeloid src-family kinase fgr potently suppresses AML cell growth in vitro and in vivo","volume":"13","author":"Weir","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.115043_bib43","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.115043_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.56773","article-title":"Phosphatidylinositol 3-phosphate and Hsp70 protect Plasmodium falciparum from heat-induced cell death","volume":"9","author":"Lu","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2022.115043_bib45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijpddr.2017.07.001","article-title":"Plasmodium falciparum in vitro continuous culture conditions: a comparison of parasite susceptibility and tolerance to anti-malarial drugs throughout the asexual intra-erythrocytic life cycle","volume":"7","author":"Duffy","year":"2017","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2022.115043_bib46","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1021\/acsinfecdis.1c00322","article-title":"Prioritization of molecular targets for antimalarial drug discovery","volume":"7","author":"Forte","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.115043_bib47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.115043_bib48","series-title":"Quinoline Derivatives and Quinazoline Derivatives Inhibiting Autophosphorylation of Growth Factor Receptor Originating in Platelet and Phamaceutical Compositions Containing the Same","author":"Kubo","year":"1997"},{"key":"10.1016\/j.ejmech.2022.115043_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2022.115043_bib50","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1073\/pnas.1118370109","article-title":"Liver-stage malaria parasites vulnerable to diverse chemical scaffolds","volume":"109","author":"Derbyshire","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2022.115043_bib51","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1021\/jm990437l","article-title":"Structure\u2212Function relationships in aminoquinolines: effect of amino and chloro groups on Quinoline\u2212Hematin complex formation, inhibition of \u03b2-hematin formation, and antiplasmodial activity","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib52","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1021\/jm701478a","article-title":"4- N -, 4- S -, and 4- O -chloroquine analogues: influence of side chain length and Quinolyl nitrogen p K a on activity vs chloroquine resistant malaria","volume":"51","author":"Natarajan","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib53","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.ejmech.2010.04.011","article-title":"Quinolines and structurally related heterocycles as antimalarials","volume":"45","author":"Kaur","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib54","doi-asserted-by":"crossref","first-page":"11865","DOI":"10.1073\/pnas.93.21.11865","article-title":"On the molecular mechanism of chloroquine's antimalarial action","volume":"93","author":"Sullivan","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2022.115043_bib55","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1021\/ol016333y","article-title":"Palladium-catalyzed synthesis of arylamines from aryl halides and lithium bis(Trimethylsilyl)Amide as an ammonia equivalent","volume":"3","author":"Lee","year":"2001","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2022.115043_bib56","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/acs.joc.6b02521","article-title":"Scalable, one-pot, microwave-accelerated tandem synthesis of unsymmetrical urea derivatives","volume":"82","author":"Kulkarni","year":"2017","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112770","article-title":"Optimization of pyrazolo[1,5-a]Pyrimidines lead to the identification of a highly selective casein kinase 2 inhibitor","volume":"208","author":"Kr\u00e4mer","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.115043_bib58","series-title":"Kinase Inhibitor Selectivity Profiling Using Differential Scanning Fluorimetry","first-page":"109","author":"Fedorov","year":"2012"},{"key":"10.1016\/j.ejmech.2022.115043_bib59","doi-asserted-by":"crossref","DOI":"10.1063\/1.3251124","article-title":"Molecular acidity: a quantitative conceptual density functional theory description","volume":"131","author":"Liu","year":"2009","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2022.115043_bib60","doi-asserted-by":"crossref","first-page":"14697","DOI":"10.1021\/jp209540p","article-title":"Modeling molecular acidity with electronic properties and hammett constants for substituted benzoic acids","volume":"115","author":"Huang","year":"2011","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.ejmech.2022.115043_bib61","first-page":"1906030","article-title":"Quantification of molecular basicity for amines: a combined conceptual density functional theory and information-theoretic approach study","volume":"36","author":"Xiao","year":"2020","journal-title":"Acta Phys. Chim. Sin."},{"key":"10.1016\/j.ejmech.2022.115043_bib62","series-title":"Gaussian 16, Revision C.01","author":"Frisch","year":"2019"},{"key":"10.1016\/j.ejmech.2022.115043_bib63","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1103\/PhysRevA.38.3098","article-title":"Density-functional exchange-energy approximation with correct asymptotic behavior","volume":"38","author":"Becke","year":"1988","journal-title":"Phys. Rev. A"},{"key":"10.1016\/j.ejmech.2022.115043_bib64","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development of the colle-salvetti correlation-energy formula into a functional of the electron density","volume":"37","author":"Lee","year":"1988","journal-title":"Phys. Rev. B"},{"key":"10.1016\/j.ejmech.2022.115043_bib65","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1063\/1.1674902","article-title":"Self\u2010consistent molecular\u2010orbital methods. IX. An extended Gaussian\u2010type basis for molecular\u2010orbital studies of organic molecules","volume":"54","author":"Ditchfield","year":"1971","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2022.115043_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wcms.51","article-title":"Natural bond orbital methods","volume":"2","author":"Glendening","year":"2012","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.115043_bib67","unstructured":"Williams, R. pKa Values. https:\/\/organicchemistrydata.org\/hansreich\/resources\/pka\/pka_data\/pka-compilation-williams.pdf (accessed 2022-May-9)."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342200945X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342200945X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T11:13:48Z","timestamp":1737285228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342200945X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":67,"alternative-id":["S022352342200945X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115043","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2022-6v14d","asserted-by":"object"}]},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of potent Plasmodium falciparum protein kinase 6 (PfPK6) inhibitors with a type II inhibitor pharmacophore","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115043"}}